Gavreto 欧盟 - 斯洛文尼亚文 - EMA (European Medicines Agency)

gavreto

roche registration gmbh  - pralsetinib - karcinom, pljučni pljuč - antineoplastična sredstva - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.

Lunsumio 欧盟 - 斯洛文尼亚文 - EMA (European Medicines Agency)

lunsumio

roche registration gmbh - mosunetuzumab - limfom, folikularni - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.

Columvi 欧盟 - 斯洛文尼亚文 - EMA (European Medicines Agency)

columvi

roche registration gmbh  - glofitamab - lymphoma, large b-cell, diffuse - antineoplastična sredstva - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.

Cotellic 20 mg filmsko obložene tablete 斯洛文尼亚 - 斯洛文尼亚文 - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

cotellic 20 mg filmsko obložene tablete

roche registration gmbh - kobimetinib - filmsko obložena tableta - kobimetinib 20 mg / 1 tableta - kobimetinib